Omnicell Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2012
January 26, 2012 at 04:30 pm
Share
Omnicell Inc. provided earnings guidance for the first quarter and full year of 2012. For the first quarter, the company expects to be $63 million to $64 million of revenue and approximately $0.13 of non-GAAP earnings per share.
For the full year, the company expects revenue to be between $263 million and $267 million, up 7% to 8%, earnings to be between $0.67 and $0.72 per share, up 14% to 22%. The company expect there to be steady growth through the year. The company's goal of 15% non-GAAP operating margins and expects to make significant progress towards this goal through 2012. And by the end of the year, expect to be very close to achieving the 15%.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Companyâs XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.